Allarity Therapeutics宣布Stenoparib Drp®检测技术获美国专利商标局审定通知

美股速递
Apr 27

Allarity Therapeutics Inc(ALLR)宣布,其开发的Stenoparib Drp®检测技术已正式获得美国专利商标局(USPTO)颁发的专利审定通知书。这一重要进展标志着该创新技术在知识产权保护方面取得关键突破,为后续商业化应用奠定法律基础。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10